跳至主要内容
临床试验/IRCT20220317054318N1
IRCT20220317054318N1招募中3 期

The effect of oral L-arginine consumption on uterine artery resistance in women with recurrent implant failure

Hamedan University of Medical Sciences0 个研究点目标入组 72 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
招募中
入组人数
72

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 41 years(—)
性别
Female

入选标准

  • Infertile women aged 18-41 years
  • Infertile IVF candidate women with a history of failure twice
  • Women with endometrium suitable for embryo transfer
  • Women with good quality embryos for transfer
  • Women who have passed 2 months or more since the last ICSI test and transfer.
  • Women who have the opportunity to attend the follow-up according to the plan and have informed consent
  • Women with a normal size and shape of the uterus that has been confirmed by ultrasound or hysteroscopy

排除标准

  • Patients who use nitrite or organic nitrate at the same time
  • Women with chronic diseases such as: severe liver, kidney, or cardiovascular failure, patients with a history of stroke or myocardial infarction
  • Women smokers
  • Women with stage 3 and 4 endometriosis
  • Women with a known etiology of implant failure such as anatomical disorders (diagnosed by hysterosalpingography), hormonal disorders, immunological disorders, trophoblasts, antiphospholipid antibodies, mutation in factor V, pro-thrombin, crew disorders Musomes are excluded from the study
  • Patients with side effects of L-arginine
  • Canceling the treatment cycle for any reason
  • Unwillingness of the person to continue participating in the study

研究者

相似试验